Lydia Lloyd
Family · Johnstown, PANPI 1598359366
Payments from drug & device makers
Across 86 payments — averaging $26.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$180
- Aurinia Pharma U.S., Inc.$177
- Astellas Pharma US Inc$175
- Vifor Pharma, Inc.$169
- Amgen$167
- Bayer$154
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,04690%
- Education$23410%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $180 |
| Aurinia Pharma U.S., Inc. | 9 | $177 |
| Astellas Pharma US Inc | 2 | $175 |
| Vifor Pharma, Inc. | 10 | $169 |
| Amgen(2 entities) | 4 | $167 |
| Bayer | 7 | $154 |
| Novo Nordisk | 3 | $140 |
| Teva Pharmaceuticals USA, Inc. | 1 | $139 |
| GSK | 2 | $130 |
| Sanofi-aventis U.S. LLC | 4 | $116 |
| AstraZeneca | 7 | $110 |
| Mallinckrodt Hospital Products Inc. | 5 | $107 |
| OPKO Pharmaceuticals, LLC | 5 | $93 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $69 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Lilly USA, LLC | 3 | $47 |
| AbbVie | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $33 |
| Pfizer | 2 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $26 |
| Boehringer Ingelheim | 1 | $17 |
| Novartis | 1 | $16 |
| Baxter Healthcare | 1 | $16 |
| Merck | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$139
- KRYSTEXXA$125
- WATCHMAN Access System$117
- BENLYSTA$113
- Saxenda$113
How this compares
$2,280 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 132 | $72,475 |
| Pantoprazole Sodium | 293 | $57,402 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 78 | $53,721 |
| XareltoRivaroxaban | 92 | $49,117 |
| Invega SustennaPaliperidone Palmitate | 14 | $48,957 |
| Atorvastatin Calcium | 447 | $42,895 |
| JardianceEmpagliflozin | 65 | $39,730 |
| OzempicSemaglutide | 37 | $37,352 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $23,653 |
| Aripiprazole | 48 | $23,234 |
| DapagliflozinDapagliflozin Propanediol | 44 | $22,151 |
| EntrestoSacubitril/Valsartan | 30 | $19,546 |
| MounjaroTirzepatide | 19 | $17,910 |
| Quetiapine Fumarate | 125 | $17,295 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 65 | $16,366 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $26 | $72,475132 claims |
| GSKTrelegy Ellipta | $130 | $53,72178 claims |
| Boehringer IngelheimJardiance | $17 | $39,73065 claims |
| Novo NordiskOzempic | $140 | $37,35237 claims |
| Lilly USA, LLCMounjaro, Olanzapine | $47 | $24,60035 claims |
| AstraZenecaBreztri Aerosphere | $110 | $23,65335 claims |
| NovartisEntresto | $16 | $19,54630 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $52 | $7,03112 claims |
| Astellas Pharma US IncMyrbetriq | $175 | $6,61218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,717 family providers in Pennsylvania.
Other family in Johnstown
- Christy JamesJohnstown$16K
- Jaclyn SpringerJohnstown$15K
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.